Literature DB >> 6983444

Selection of the T cell repertoire during ontogeny: limiting dilution analysis.

H S Teh, J Bennink, H Von Boehmer.   

Abstract

The relative frequencies of cytotoxic T lymphocyte precursors (CTL-P) specific for minor histocompatibility antigens that are restricted to either k or b major histocompatibility complex antigens in normal B6 mice and in B6 leads to (B6 x CBA)F1 radiation chimeras were estimated. The ratio of k-restricted to b-restricted CTL-P determined for the radiation chimeras served as a base value to which the ratio of k: b-restricted CTL from normal B6 mice can be compared. The frequencies of allorestricted CTL-P in B6 mice were determined after the B6 cells had been depleted of k-reactive cells by filtration through irradiated B6.H-2k mice. Lymphocytes from immunized animals were used to obtain frequency estimates of CTL-P specific for minor H antigens. The cultures contained nu/nu spleen cells syngeneic to the responder, but no exogenous interleukin 2 (T cell growth factor) since a high degree of nonspecific killing was found in IL2-supplemented cultures. It was found that the CTL-P frequency of B6 mice to BALB.B antigens in the lymph node cells of normal or immune B6 mice were 1 in 300 000 and 1 in 8000, respectively. In B6 leads to (B6 x CBA)F1 radiation chimeras, the ratio of BALB.B/BALB.K-specific CTL-P was 3:1; this ratio was 17:1 in normal B6 mice. Twenty-five percent of CTL clones from normal B6 mice lysing BALB.K target also lysed BALB.B target whereas less than 1% of CTL clones lytic on BALB.K target from the chimeras showed this cross-reaction The results are compatible with the idea of complete positive selection of self MHC-restricted CTL-P in the absence of priming effects by foreign antigen.

Entities:  

Mesh:

Year:  1982        PMID: 6983444     DOI: 10.1002/eji.1830121016

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  8 in total

Review 1.  Death and destruction of activated T lymphocytes.

Authors:  I N Crispe
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  Peripheral tolerance in mice expressing a liver-specific class I molecule: inactivation/deletion of a T-cell subpopulation.

Authors:  K Wieties; R E Hammer; S Jones-Youngblood; J Forman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

3.  Characterization of a Db-specific helper factor required for the induction of cytotoxic responses to alloantigens with the use of monoclonal antibodies specific for the helper factor or the T-cell antigen receptor.

Authors:  P C Kwong; H S Teh
Journal:  Immunology       Date:  1987-06       Impact factor: 7.397

4.  The analysis of an anti-fluorescein response at limit dilution: the effect of lymphokine preparations on the apparent specificity.

Authors:  M A Skinner; R Prestidge; J Marbrook
Journal:  Immunology       Date:  1985-07       Impact factor: 7.397

5.  Clones of cytotoxic T lymphocytes reactive to haptenated allogeneic cells: precursor frequency and characteristics as determined by a split-culture approach.

Authors:  M F Good; G J Nossal
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

6.  Primary vascularization of the graft determines the immunodominance of murine minor H antigens during organ transplantation.

Authors:  Jean Kwun; Subramaniam Malarkannan; William J Burlingham; Stuart J Knechtle
Journal:  J Immunol       Date:  2011-09-07       Impact factor: 5.422

7.  Clonal analysis of helper and effector T-cell function in neonatal transplantation tolerance: clonal deletion of helper cells determines lack of in vitro responsiveness.

Authors:  P J Wood; P G Strome; J W Streilein
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

8.  Subdominant H60 antigen-specific CD8 T-cell response precedes dominant H4 antigen-specific response during the initial phase of allogenic skin graft rejection.

Authors:  Kang Il Yoo; Ji Yeong Jeon; Su Jeong Ryu; Giri Nam; Hyewon Youn; Eun Young Choi
Journal:  Exp Mol Med       Date:  2015-02-13       Impact factor: 8.718

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.